Blood thyrotropic hormone, thyroxin, tri-iodothyronine, FSH, LH, estradiol and progesterone levels were examined in 14 patients with primary hypothyroidism and 11 normal women of reproductive age. All the women under study were subjected to functional tests with intravenous thyroliberin (TRH) and metoclopramide. All hypothyroid patients had anovulatory infertility. Hyperprolactinemia was detected in 8 of 14 patients. It is demonstrated that hyperprolactinemia, developing in cases of primary hypothyroidism, is associated with impaired dopaminergic inhibition of pituitary lactotropics. Substitution thyroidin therapy resulted in the recovery of the normal ovulatory cycle in all but one patient with secondary pituitary microprolactinoma, and 8 patients became pregnant. It is believed that damaged dopaminergic regulation of hypothalamic luliberin (RH) secretion is a direct cause of ovarian dysfunction associated with primary hypothyroidism.

Download full-text PDF

Source

Publication Analysis

Top Keywords

primary hypothyroidism
12
[hypothyroidism hyperprolactinemia]
4
hyperprolactinemia] blood
4
blood thyrotropic
4
thyrotropic hormone
4
hormone thyroxin
4
thyroxin tri-iodothyronine
4
tri-iodothyronine fsh
4
fsh estradiol
4
estradiol progesterone
4

Similar Publications

Background: Numerous studies have demonstrated limited survival benefits of transarterial chemoembolization (TACE) alone in the treatment of intermediate-stage hepatocellular carcinoma (HCC) beyond up-to-seven criteria. The advent of immunotherapy, particularly immune checkpoint inhibitors (ICIs), has opened new avenues for HCC treatment. However, TACE combined with ICIs has not been investigated for patients with intermediate-stage HCC beyond the up-to-seven criteria.

View Article and Find Full Text PDF

Seasonal Fluctuation in the Incidence of Congenital Hypothyroidism Across Different Temperate Zones of China.

Birth Defects Res

January 2025

National Center for Birth Defects Monitoring, West China Second University Hospital, Sichuan University, Chengdu, China.

Background: Seasonality in the incidence of congenital hypothyroidism (CH) has been identified in several countries and different conclusions have been drawn. The objective of this study was to examine whether this seasonality is also observable in China and how it manifests across different temperate zones.

Methods: Data on CH cases and screened neonates between January 1, 2014, and September 30, 2022, by year and season, were sourced from the Chinese Newborn Screening Information System.

View Article and Find Full Text PDF

In this case, the message is conveyed that after ruling out sinister causes of hypotension, endocrine causes should also be considered, particularly in the light of a relatively long history, absence of any sepsis and organ dysfunction, preserved urine output, euvolemic status, and with no significant response to intravenous fluid. In our case, a patient with hypotension with relatively stable other clinical parameters has been evaluated to reveal pituitary macroadenoma as an underlying diagnosis.

View Article and Find Full Text PDF

Thyroid hormones in systemic lupus erythematosus: the catalyst for disease progression?

Am J Med Sci

January 2025

Henan Provincial People's Hospital, Henan Provincial Clinical Research Center for Kidney Disease, Henan Key Laboratory of Nephrology and Immunology, Zhengzhou 450003, Henan, China. Electronic address:

Objective: The study aimed to investigate the impact of varying thyroid function statuses on clinical and laboratory indicators in patients with systemic lupus erythematosus (SLE).

Methods: A retrospective analysis was conducted on 258 patients with SLE, who were stratified according to thyroid function, renal involvement, and disease activity. The predictive value of thyroid hormones was evaluated using a receiver operating characteristic (ROC) curve.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!